GBT Receives Patent Grant Notification Covering its Integrated Circuits Reliability Verification Analysis and Auto-Correction Technology

The Patent is scheduled for Grant on September 19, 2023

SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- GBT Technologies Inc. () ("GBT” or the “Company”), received a grant notification for its microchip’s reliability verification and auto-correction EDA patent application, internal project’s code name, Epsilon. The patent will be granted as U.S. Patent No. 11,763,062 on September 19, 2023. GBT’s Epsilon patent application covers the innovative technology to address advanced semiconductor node physics with the goal of ensuring a high level of reliability, optimal thermal design, lower power consumption and high performance. The described technology includes machine learning algorithms to enable robust design, process optimization, characterization, modeling, and simulation. The technology underlying the patent identifies reliability flaws, describes the found issues, and allows an automatic correction of these reliability issues early during the IC’s design phase. Machine Learning techniques will be performing data analysis, identification, categorization, and reasoning about executing the optimal IC layout automatic correction. The technology aims to allow IC designers to analyze and fix circuits early during the design phase in real time with the goal of creating higher efficiencies. GBT plans to continue its R&D efforts in this domain, inventing modern technologies and enabling reliable, low-power, high-performance, next-generation microchips.

“We are excited to share that our Epsilon patent has been granted. This patent aims to perform an early electrical and power analysis of a microchip during the design phase. The goal is to identify potential failures and provide solutions as early detection and elimination of reliability issues can save a significant amount of time in engineering redesign. The technology is planned to be powered by GBT's machine learning algorithms for pattern recognition and vast data analysis, especially for advanced manufacturing nodes like 3nm and below.

"Today's advanced nanometer nodes require analysis and addressing of reliability parameters to mitigate risks of system degradation, overheating and possible malfunctions. As IC's manufacturing nodes are constantly scaling down, layout electrical characteristics analysis is becoming a much more complex and time-consuming process, addressing challenging physics phenomenon. Our Epsilon patent is an intelligent design productivity enhancement EDA software solution that analyzes, detects, and eliminates electrical reliability issues on-the-fly. Its goal is to enable chip designers to keep their hands on the pulse of the entire microchip's reliability, power management, thermal behavior and overall performance.

"Microchip reliability is a complex and evolving field. As such, we plan to continue our ongoing research and development efforts to address emerging challenges associated with shrinking nanometer-scale technologies. Additionally, we plan to file a continuation for this technology, with the goal of further broadening and protecting our intellectual "property” stated Danny Rittman, the Company’s CTO.

There is no guarantee that the Company will be successful in researching, developing or implementing this system. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched and fully developed, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.

About Us

GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) () is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

Contact:

Dr. Danny Rittman, CTO